T raumatic brain injury (TBI) is a common cause of disability and death in children. Those with severe TBI, defined as a Glasgow Coma Scale (GCS) score less than 8, are at risk of refractory intracranial hypertension (RICH) and low cerebral perfusion pressure (CPP) (1). Barbiturates are recommended as a second-tier therapy to control RICH with potential benefits, but known toxicities, particularly hypotension (2-4). Recent studies of severe TBI report continued barbiturate use in both children and adults (3-5); however, impact on outcome remains controversial in adult patients and not evaluated in children (6, 7).
T raumatic brain injury (TBI) is a common cause of disability and death in children. Those with severe TBI, defined as a Glasgow Coma Scale (GCS) score less than 8, are at risk of refractory intracranial hypertension (RICH) and low cerebral perfusion pressure (CPP) (1) . Barbiturates are recommended as a second-tier therapy to control RICH with potential benefits, but known toxicities, particularly hypotension (2) (3) (4) . Recent studies of severe TBI report continued barbiturate use in both children and adults (3) (4) (5) ; however, impact on outcome remains controversial in adult patients and not evaluated in children (6, 7) .
Research specific to clinical effects of high-dose barbiturates in children is limited to two case series reported 20 yr ago when Objectives: To evaluate high-dose barbiturates as a second-tier therapy for pediatric refractory intracranial hypertension complicating severe traumatic brain injury. Design: This is a retrospective cohort study of children with refractory intracranial hypertension treated with high-dose barbiturates. Setting: A single center level I pediatric trauma from 2001 to 2010. Patients: Thirty-six children with refractory intracranial hypertension defined as intracranial pressure greater than 20 mm Hg despite standard management treated with high-dose barbiturates after severe traumatic brain injury. Interventions: High-dose barbiturates were administered for refractory intracranial hypertension for a minimum duration of 6 hours and monitored by continuous electroencephalography. Measurements and Main Results: Exposure was control of refractory intracranial hypertension defined as > 20 mm Hg within 6 hours after starting barbiturates. Pediatric cerebral performance category scores at hospital discharge and at 3 months (or longer) follow-up were the primary outcomes. Ten of 36 patients (28%) had control of refractory intracranial hypertension. Neither demographic nor injury characteristics were associated with refractory intracranial hypertension control. Children who responded received barbiturates significantly later after injury (76 vs. 29 median hours). Overall, 14 children died, 13 without control of intracranial pressure. Survival was more common in those who responded compared with those who did not respond to high-dose barbiturates, although this did not reach statistical significance ( TBI treatment differed substantially from contemporary care (8, 9) . High-dose barbiturates lower intracranial pressure (ICP) in some children with RICH; however, hemodynamic impairment is common (8) .
Care of severe TBI at our hospital has mirrored the care pathway recommended in original pediatric severe TBI guideline flowchart (4) since 2001 with goal-directed CPP for age and control of ICP. We sought to determine whether high-dose barbiturate therapy controls ICP in children with RICH despite standard therapies. We also evaluated functional outcome at hospital discharge and longer-term outcomes associated with control of RICH.
METHODS
This is a retrospective cohort of infants and children admitted to Primary Children's Medical Center (PCMC) from January 2001 to December 2010 who received high-dose barbiturate therapy for RICH complicating TBI to a goal of burst suppression on electroencephalography monitoring. PCMC is a free-standing, American College of Surgeonsverified level I pediatric trauma center serving five states in the western United States admitting roughly 630 TBI victims annually, approximately 200 to the pediatric intensive care unit. The hospital's trauma database was used to ascertain the number of TBI patients treated during the study period with mechanical ventilation for at least 2 days in order to estimate our institutional use of high-dose barbiturates for severe TBI.
All children with severe TBI treated with a barbiturate infusion for RICH, defined as ICP greater than 20 mm Hg, were eligible for inclusion (n = 38). To further refine the study population to patients treated with barbiturate coma, patients who received barbiturate infusions for less than 6 hours were excluded (n = 2). Demographic, clinical, and outcome data were collected by abstraction from electronic and paper medical records and query of the trauma database. The study was approved by the University of Utah Institutional Review Board and granted a waiver of informed consent.
During the study period, patients with RICH were managed using a protocol that mirrors the Brain Trauma Foundation's guidelines (4) (Fig. 1) . Patients with severe TBI were routinely monitored with arterial and central venous pressure catheters and ICP monitoring using an external ventricular drain, an intraparenchymal fiberoptic monitor (Camino ICP Monitors 110 4B; Camino Laboratories, San Diego, CA) or both. Decisions regarding monitor type were made by the neurosurgery service based on depth of coma, need for emergency surgical treatment, and radiographic imaging. Care was titrated to achieve daily goals for ICP (typically less than 20 mm Hg) and CPP (between 40 and 65, based on patient age). In this cohort, first-tier measures were insufficient to control RICH and high-dose barbiturate therapy was initiated for uncontrolled RICH.
Pentobarbital was routinely administered with a loading dose followed by a continuous infusion titrated to a goal of electrographic burst suppression; however, exact dosing was not standardized.
The first available non-contrast head CT for each patient was reviewed to identify specific injuries and assign a Rotterdam CT score (10) by a pediatric neuroradiologist blinded to patient outcome. However, seven initial CT scans were unavailable due to digital image migration loss.
Mechanism of injury was divided into motorized, nonmotorized, and non-accidental trauma (NAT). NAT was determined by the hospital's child abuse team. Markers of injury severity, including GCS, injury severity score (ISS), and any pre-trauma center cardiac arrest were recorded. Type of admission (e.g., direct from scene to trauma center or transfer from outlying hospital) and time from injury to trauma center admission were recorded.
Clinical features, including therapies used to treat elevated ICP prior to initiation of barbiturate infusion, were recorded. Time of burst suppression was sporadically documented in the medical record and thus notations regarding burst suppression were recorded as present, absent, or unknown. After initiation of barbiturates, all hourly measurements of ICP and CPP were recorded from nursing notes. Routine nursing practice is to record abnormal pressures if maintained for at least 5 minutes. Age appropriate CPP goals, which were specified daily by the clinical team for all patients, were noted and low CPP was defined as a measurement greater than 3 mm Hg below the target CPP.
Other information collected daily included use of vasoactive medications, blood tests, and highest ventilator settings. Severe hypoxia was defined as a PaO 2 /FIO 2 ratio less than 200. Nosocomial infections recorded were bacteremia, urinary tract infections, and gastrointestinal infections. Ventilator-associated pneumonia was defined as a new infiltrate on chest radiograph with clinical signs. Renal insufficiency was defined as a doubling in baseline creatinine.
RICH was defined as an ICP greater than 20 mm Hg despite first-tier therapies. Uncontrolled RICH was defined as two consecutive hourly ICP measurements greater than 20 mm Hg occurring after the initial 6 hours of barbiturate infusion (3). This 6-hour lag period was chosen to account for escalation of barbiturate therapy when working toward steady state and burst suppression.
Primary outcomes were discharge pediatric cerebral performance category (PCPC) scores (11, 12) and long-term PCPC scores assessed at least 3 months after injury (when available). The PCPC score provides a scale to evaluate functional morbidity and cognitive impairment in pediatric patients after critical injury. Pediatric physical medicine and rehabilitation clinical notes were preferentially reviewed for retrospective PCPC scoring by two pediatric critical care physicians independently (S.B., K.B.). Differences in scores were resolved by consensus. Among children without follow-up, the hospital discharge PCPC was imputed as the long-term PCPC score (n = 7). An adequate outcome was defined as a PCPC score of 1-3, while a poor outcome was a PCPC score of 4-6 (13).
Summary statistics were generated for the study groups based on control of RICH and were evaluated using a Fisher's www.pccmjournal.org exact test for categorical data and Mann-Whitney U test for continuous data. The relative risk ratio (RR) and 95% confidence intervals (CIs) were calculated based on control of RICH. A logistic model evaluating factors associated with uncontrolled RICH was developed using stepwise forward logistic regression. Factors considered in the model were those associated in the bivariate analysis with a p value of less than 0.1 and model inclusion requirements were a p value less than 0.05. Kaplan-Meier curves were generated by exposure and time to death after injury evaluated with the log rank test. All statistical analyses were done using SPSS 18.0 (SPSS, Chicago, IL) and defined significance as a p value less than 0.05.
RESULTS
During the 10 yr studied, 778 TBI patients received mechanical ventilation for 2 days or more and 36 (5%) met study criteria. Original CT scans were unavailable for one patient in the control group and six patients in the uncontrolled group.
Ten (28%) patients had RICH controlled (ICP < 20 mm Hg) within 6 hours after starting high-dose barbiturates, while 26 patients did not ( Table 1) . Neither demographic nor injury features differed significantly between groups. All patients had an ICP monitor, and 33 (92%) had an external ventricular drain. Lumbar drains were used in four (11%) children, and a decompressive craniectomy was performed in 16 (44%). Of note, one patient received a decompressive craniectomy after initiation of barbiturate therapy, and one patient had two separately located decompressive craniectomies, one before and one during barbiturate therapy. Thus 16 patients had RICH despite craniectomy. The proportion of patients with controlled and those with uncontrolled RICH did not differ by any surgical interventions. None of the pre-high-dose barbiturate TBI medical therapies differed between RICH groups, although patients in the uncontrolled group demonstrated a non-significant trend to receive more alpha agents (Fisher's exact; p = 0.06). Patients were not routinely hyperventilated and hypothermia was not employed although hyperthermia was treated.
Features of high-dose barbiturate therapy are shown in Table 2. Children in whom RICH was controlled had barbiturate therapy initiated significantly later after injury (76 vs. 29 median hours) and had significantly lower ICP measured just prior to initiation of high-dose barbiturate therapy. However, all patients except one who had a posterior fossa crainectomy had ICP measurements greater than 20 mm Hg after starting barbiturates. Thirty-one (86%) were recorded greater than 20 mm Hg in the first 6 hours of recorded nursing measurements, two (5%) patients during hours 7-12, and two (5%) in hours 13-18. Barbiturate infusions continued for a similar median duration (56 vs. 90 hours). Of 36 children, 30 had documented burst suppression during barbiturate therapy, one child failed to achieve burst suppression, and the medical records were not clear in five. One patient was in burst suppression from propofol for seizure control prior to barbiturate infusion.
All children with RICH control within 6 hours continued in control during the first 24 hours after injury. One child in this group underwent a posterior fossa decompressive craniectomy with left hemisphere cerebellar resection, received barbiturate therapy for less than 24 hours, and died. Conversely, among the 26 children with uncontrolled RICH after 6 hours of high-dose barbiturate therapy, only one (4%) achieved RICH control between hours 7 and 24. Eighteen (69%) of these patients continued to have RICH during hours 7-24, while seven (27%) were treated for less than 24 hours and five of seven (71%) died. Six (17%) of 36 children experienced at least one episode of severe hypoxia on day 1 of high-dose barbiturate infusion. Incidence of hypoxia on subsequent days remained similar and did not differ significantly between groups. Patients in both groups had similar rates of nosocomial infections. Ventilatorassociated pneumonia occurred in nine patients (25%) and six (17%) had a urinary tract infection. One patient (4%) acquired a gastrointestinal infection and one (4%) developed a catheter-associated blood stream infection.
Patient groups had similar median ICU (14 vs. 12 days) and hospital (29 vs. 17 days) lengths of stay ( Table 4) . A lower risk of death in those with controlled RICH was found (RR 0.2; 95% CI [0.03-1.3]); however, this was not statistically significant. Adequate hospital survival showed a similar beneficial Excludes children who died (n = 14) and retains the discharge PCPC for those without follow-up (n = 7). c Excludes children who died (n = 14) and those without follow-up (n = 7).
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March 2013 • Volume 14 • Number 3 trend associated with controlled RICH (RR 2.2; 95% CI [0.9-5.5]) compared with those with uncontrolled RICH, though also not statistically significant. Survival after injury is shown in Figure 2 , and those with RICH had significantly greater survival (log rank test, p = 0.047) compared with those with persistent RICH. Death occurred over a range of barbiturate treatment days (1-15 days) .
At discharge, median PCPC scores were significantly better in the controlled RICH group (Table 4) . However, among patients with controlled RICH, 30% had moderate disability and 40% had severe disability at hospital discharge. When dichotomized between "acceptable" (PCPC 1-3) and poor outcomes (PCPC 4-6), functional outcome did not significantly differ between groups at hospital discharge. Three of 16 (19%) patients treated with a decompressive craniectomy prior to barbiturate initiation had an acceptable hospital outcome compared with 8 of 21 (38%) who did not have a craniectomy (p = 0.28).
Twenty-two (61%) children survived to hospital discharge. Fifteen (68%) returned for care and a PCPC score was determined from the rehabilitation specialty note (n = 11) or neurosurgery/neurology (n = 2) and other clinical services (n = 2) notes at least 3 months after injury. All children who survived to hospital discharge with a poor outcome were seen at least once after discharge, and the patients missing follow-up all had a hospital discharge PCPC less than 3. Nineteen (53%) of all study patients had an "acceptable" survival. Three of 13 children who survived despite RICH remained severely disabled compared with 0 of 9 with controlled RICH. Among survivors, the median PCPC was significantly better for those with controlled RICH. Likewise, control of RICH was associated with over two-fold risk of acceptable long-term outcome (RR 2.3; 95% CI 1.4-4.0). Maintenance of goal CPP was not independently associated with long-term outcome in logistic models whether CPP maintenance was treated as continuous (i.e., number of documented pressures greater than 3 mm Hg below goal) or as a binary variable (ever vs. never below target).
DISCUSSION
In 36 children with severe TBI treated with high-dose barbiturates as a second-tier RICH therapy, 28% had control of RICH. Half with continued RICH died while 10% with control died during the hospital stay. Hemodynamic compromise was frequent but not significantly associated with hospital mortality or long-term outcomes. Control of RICH was associated with over two-fold increased rate of acceptable long-term survival. Although longterm functional outcome among survivors in both ICP groups was encouraging (83% achieving "acceptable" functional longterm outcome), only 8% improved to normal function.
Almost one-third had RICH controlled with high-dose barbiturate treatment. Prior studies report control of ICP from 22% to 52% (2, 3, 9) . The only factors associated with RICH control were greater time elapsed after injury to initiation of high-dose barbiturate therapy and lower ICP at barbiturate therapy initiation. Time of barbiturate initiation in responders may reflect less severe injury or differences in efficacy for treatment of primary versus secondary injury (14) . Use of barbiturate therapy in our patients was later than reported by Hutchinson et al where 76% started within 24 hours of injury (5) . Although all patients in our study had RICH prior to initiation of high-dose barbiturates, the ICP just prior to administration was lower in the group that had RICH controlled. Marshall et al (3) did not find a trend for control of ICP with high-dose barbiturates therapy and severity of Marshall CT score in adults. Likewise, Farahvar et al reported no statistical association between status of the basilar cisterns with likelihood of ICP control among head-injured patients aged 16 years and older (15) .
Failure of high-dose barbiturates to control RICH was associated with decreased time to death and a trend for a five-fold increased risk of death. Uncontrolled RICH is associated with slightly greater hospital mortality in adults (72% to 83%) (2, 3) Time of death after injury was variable, which differs from the report of 27 children treated with barbiturates (9) that found all (n = 6, 22%) deaths occurred within 2 days after starting highdose barbiturates. In Pittman's case series of the 13 children who failed to respond to barbiturates, seven (54%) survived, five with mild to moderate disability at 12 months after injury. Similarly, half of our patients with persistent RICH survived, and long-term outcome was "acceptable" among 10 of 13 survivors. Among children with follow-up examinations, PCPC scores improved a median of one post discharge and no child worsened.
Cardiovascular compromise was common, reflected by near universal receipt of vasoactive medications and frequently recorded low CPPs. Although low CPP was common, we did not find an independent association with poor outcome or death after adjustment for RICH control. Hypotension increases risk of death and poor outcome in both adults and children with severe TBI (16) (17) (18) (19) . Failure to demonstrate an independent association with low CPP may be limited by the relatively small sample size or inadequate ascertainment of its frequency and severity. A recent secondary analysis from the Canadian pediatric hypothermia trial demonstrated an association between low CPP and outcome; however, the effect size was smaller compared with hypotension and the analysis did not adjust for control of ICP (20) . Contrary to our findings, a recent study of over 1400 adult patients reported that intracranial hypertension and CPP were independently associated with death (15) .
Our use of high-dose barbiturates was 5%, which appears similar to Hutchison et al (5) . Of the screened patients in the Hutchison study with GCS score less than 8, about 6% received barbiturate therapy. Contemporary use in adults (3) is about 1%. Comparison with these recent studies suggests that our center approximates current North American TBI care related to frequency of high-dose barbiturate therapy for RICH.
There are several study limitations. We used retrospectively collected data. Our definition of time to response to high-dose barbiturate therapy was similar to Marshall et al (3) but relied on nursing records. However, this definition would have been fairly consistent at 24 hours as only a single patient would have changed groups. Administration of barbiturate therapy was non-uniform, but the treatment goal was to achieve burst suppression with control of ICP. Documentation of burst suppression was sporadic and time to burst suppression was not available. This study contains a relatively small sample size, but it is the largest report to date evaluating high-dose barbiturates in children. Available followup records were inconsistent and seven were missing. One patient was discharged home to the eastern United States; the other six patients were treated early in the study period before implementation of electronic medical records. It is difficult to predict the effect on our outcomes due to the patients lost to follow-up. For these we assumed no change in PCPC scores, which may be a pessimistic bias as patients may improve with time.
CONCLUSIONS
Nearly 30% of children with RICH complicating severe TBI gained control of ICP with barbiturate therapy. The need for hemodynamic support and periods of lower CPP were common. RICH control was associated with "acceptable" long-term functional outcome and better PCPC scores among survivors; yet only one-quarter of those who survived despite persistent RICH had severe disabilities.
